SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 19, 2005
Commission File Number: 000-21376
Bio-Life Labs, Inc.
-------------------
(Exact name of registrant as specified in its charter)
Nevada 33-0714007
------- ----------
(State or other jurisdiction of (I.R.S. Employer Identification No.)
incorporation or organization)
9911 West Pico Boulevard, Suite 1410, Los Angeles, California 90035
-------------------------------------------------------------- -----
(Address of principal executive offices) (Zip Code)
(310) 277-5333
--------------
(Registrant's Telephone Number, Including Area Code)
ITEM 2.03: CREATION OF A DIRECT FINANCIAL OBLIGATION OR AN OBLIGATION UNDER AN
OFF-BALANCE SHEET ARRANGEMENT OF THE COMPANY.
Bio-Life Labs, Inc., a Nevada corporation (the "Registrant") has received
payments totaling $ 137,000 as advances on two proposed transactions that have
not yet been committed to writing or consummated.
At the time such agreements are entered into by the Registrant, these agreements
will be filed by the Registrant as an amendment to this report.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
Bio-Life Labs, Inc.
January 19, 2005 By: /s/ Nancy LeMay
--------------------------
Nancy LeMay, President